Network
The large node is Hubrx LTD. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 6
- Jason Elliot Lestner 2023-2024 View profile
- Michael Raymond Hewitson 2020-2022 View profile
- Jennifer May Alice Riddell 2020-2022 View profile
- Sean Douglas Riddell 2019-2022 View profile
- Howard Beggs 2019-2022 View profile
- Stephanus Janke 2019-2019 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- Incorporated
- 06/09/2019
Ownership
Owned by (2) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Daniel Mark Lee ceased 2022-07-05
25-50% shares, 25-50% voting · notified 2019-09-06 - confirmed: also a director of this company - Hubrx Holdings Limited
75-100% shares, 75-100% voting, appoints directors · notified 2022-07-05
Group
- Hubrx LTD
is controlled by Daniel Mark Lee
Evidence
ceased 25-50% shares, 25-50% voting · notified 2019-09-06, ceased 2022-07-05 · source: Companies House PSC register
Ultimately controlled by Daniel Mark Lee.
12 other companies in this group
- Pharmacy Plus Health Limited
- LP SD Twenty ONE Limited
- Living Care Pharmacy (North Leeds) Limited
- Cloudrx LTD
- Living Care Limited
- Living Care Pharmacy Limited
- TPG Ventures Limited
- Molecule Group Limited
- Living Care Pharmacy (South Leeds) Limited
- Hubrx Holdings Limited
- Living Care Pharmacy (Wakefield) Limited
- Pharmacy Plus Health (Bidco) Limited
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Financials
- Net assets
- -£5,915,516
- Total assets
- £15,492,341
- Cash
- £94,594
- Employees
- 19
- Turnover
- £7,287,229
- Profit/loss
- -£3,635,445
Filed as Full accounts.
Figures from accounts filed at Companies House (iXBRL), period ending 2025-03-31. Where turnover is absent, small and micro-entity accounts are not required to report it, so it is not shown as zero.
Board analysis for researchers
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
5 directors on the board
- Karl Wooldridge Director · appointed 2022
- Mark Pedder Director · appointed 2022
- Carl Richard Tate Director · appointed 2025
- Daniel Mark Lee Director · appointed 2019
- Dr Sarah Passmore Director · appointed 2022
Directors past 6 years
- Daniel Mark Lee Director · appointed 2019
First-time vs portfolio directors
First-time (3)
- Karl Wooldridge Director · appointed 2022
- Mark Pedder Director · appointed 2022
- Carl Richard Tate Director · appointed 2025
Portfolio (2)
- Daniel Mark Lee Director · appointed 2019
- Dr Sarah Passmore Director · appointed 2022
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 12192691
- Status
- Active
- Type
- Private Limited Company
- Edition
- Register edition compiled 20th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data